ZORVOLEX
is a nonsteroidal anti-inflammatory drug that provides for the treatment of acute and osteoarthritis pain... Read moreZORVOLEX
is a nonsteroidal anti-inflammatory drug that provides for the treatment of acute and osteoarthritis pain... Read more
CEO
Add
Est. Annual Revenue
$5M
Est. Employees
50
News
Dec 07, 2016
PR Newswire
Press Release: ZORVOLEX : Iroko Provides Update in Relation to Zorvolex®
May 14, 2015
BIOSPACE
ZORVOLEX: Iroko Pharmaceuticals Announces First International Launch Of ZORVOLEX
May 06, 2015
FINANZNACHRICHTEN.DE
ZORVOLEX: Iroko Pharma Announces Addl. International Licensing Deal For ZORVOLEX
Nov 16, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : CORRECTING and REPLACING New Long-Term Safety and Quality of Life Data Reported for ZORVOLEX® in Osteoarthritis Patients
Nov 03, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : Iroko Pharmaceuticals to Present New ZORVOLEX® Osteoarthritis Data at American College of Rheumatology 2014 Annual Meeting
Oct 28, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : Iroko Pharmaceuticals Announces New Strategic Agreement to Commercialize ZORVOLEX® in Australia and New Zealand
Oct 21, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : Iroko Pharmaceuticals Signs New Strategic Agreement With Landsteiner Scientific to Bring ZORVOLEX® to Mexico
Sep 03, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : Iroko Pharmaceuticals Announces Inclusion of ZORVOLEX® in Key 2015 National Formularies
Jul 08, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : Iroko Pharmaceuticals Announces First International Filing for ZORVOLEX®
Mar 25, 2014
BUSINESS WIRE
Press Release: ZORVOLEX : Iroko Pharmaceuticals Announces Key Patent Grant for ZORVOLEX™
ZORVOLEX Competitors
1
2
3
4
5
6
7
8
9
10